Targeting copper in cancer therapy: 'Copper That Cancer'

D Denoyer, S Masaldan, S La Fontaine, MA Cater - Metallomics, 2015 - academic.oup.com
Copper is an essential micronutrient involved in fundamental life processes that are
conserved throughout all forms of life. The ability of copper to catalyze oxidation–reduction …

Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities

M Sedighi, A Zahedi Bialvaei, MR Hamblin… - Cancer …, 2019 - Wiley Online Library
Successful treatment of cancer remains a challenge, due to the unique pathophysiology of
solid tumors, and the predictable emergence of resistance. Traditional methods for cancer …

Current biomedical use of copper chelation therapy

S Baldari, G Di Rocco, G Toietta - International journal of molecular …, 2020 - mdpi.com
Copper is an essential microelement that plays an important role in a wide variety of
biological processes. Copper concentration has to be finely regulated, as any imbalance in …

Monotherapy and combination therapy using anti‐angiogenic nanoagents to fight cancer

P Liang, B Ballou, X Lv, W Si, MP Bruchez… - Advanced …, 2021 - Wiley Online Library
Anti‐angiogenic therapy, targeting vascular endothelial cells (ECs) to prevent tumor growth,
has been attracting increasing attention in recent years, beginning with bevacizumab …

The anti-angiogenic basis of metronomic chemotherapy

RS Kerbel, BA Kamen - Nature Reviews Cancer, 2004 - nature.com
In addition to proliferating cancer cells and various types of normal cells, such as those of
the bone marrow, conventional cytotoxic chemotherapeutics affect the endothelium of the …

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases

F Winkler, SV Kozin, RT Tong, SS Chae, MF Booth… - Cancer cell, 2004 - cell.com
The recent landmark Phase III clinical trial with a VEGF-specific antibody suggests that
antiangiogenic therapy must be combined with cytotoxic therapy for the treatment of solid …

Roadmap for metal nanoparticles in radiation therapy: Current status, translational challenges, and future directions

J Schuemann, AF Bagley, R Berbeco… - Physics in Medicine …, 2020 - iopscience.iop.org
This roadmap outlines the potential roles of metallic nanoparticles (MNPs) in the field of
radiation therapy. MNPs made up of a wide range of materials (from Titanium, Z= 22, to …

Disrupting tumour blood vessels

GM Tozer, C Kanthou, BC Baguley - Nature Reviews Cancer, 2005 - nature.com
Low-molecular-weight vascular-disrupting agents (VDAs) cause a pronounced shutdown in
blood flow to solid tumours, resulting in extensive tumour-cell necrosis, while they leave the …

Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging

VB Pillai, NR Sundaresan, MP Gupta - Circulation research, 2014 - Am Heart Assoc
Cardiac hypertrophy is a multifactorial disease characterized by multiple molecular
alterations. One of these alterations is change in the activity of Akt, which plays a central role …

Tumor hypoxia in cancer therapy

JM Brown - Methods in enzymology, 2007 - Elsevier
Human solid tumors are invariably less well‐oxygenated than the normal tissues from which
they arose. This so‐called tumor hypoxia leads to resistance to radiotherapy and anticancer …